# Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0

> **NCT02756013** · PHASE2 · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Gynecologic Malignancies

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02756013
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-04-20
- **Primary completion:** 2018-08-16
- **Final completion:** 2019-01-24
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Lack of accrual - terminated
- **Last updated:** 2022-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02756013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02756013, "Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02756013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*